P15.03 A Phase 1/1b Study of Lazertinib As Monotherapy and in Combination with Amivantamab in Advanced EGFR-Mutated NSCLCK. Goto,T. Hida,N. Funami,R. Iwasawa,S. Mita,Y. Botilde,A. Yamashita,Y. Inoh,N. Haddish-Berhane,J. Xie,A. Roshak,R.E. Knoblauch,Y. OheJournal of thoracic oncology（2021）引用 2|浏览7暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
